Researchers determine the structure of nanomachine essential for functioning of mTOR
The principle that form follows function does not only apply to design and architecture. It also applies to biology. Every […]
A blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new […] According to researchers at Marshall University, a maternal diet rich in Omega-3 fatty acids protects from breast cancer development in […] According to the recent statistics, more and more people are being diagnosed with colorectal cancer. However, not everyone is actually […] WEHI has partnered with Boehringer Ingelheim, a leading research-driven pharmaceutical company, in a collaboration to discover and develop anti-cancer therapeutics […] Several studies have associated blood lipids with different types of cancer like that of the food pipe or “esophagus,” but […] Increased risk of cancer due to a genetic predisposition in first- and second-degree relatives is long-established but has previously only […] The Endocrine Society today praised the U.S. Supreme Court's decision to uphold the Affordable Care Act, which makes health care […] The cost of cancer care in United States was an estimated $183 billion in 2015 and is projected to rise […] Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib […]cancer
Flinders University trial to evaluate new blood test for personalized cancer treatment
Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring
American Cancer Society Drops Ideal Screening Age at 45
WEHI collaborates with Boehringer Ingelheim to develop novel anti-cancer therapeutics
Family history modifies the link between blood lipids and esophageal cancer risk
Family-based cancer clustering occurs more frequently among minority populations, study shows
Endocrine Society praises U.S. Supreme Court's decision to uphold the ACA
Study reveals the impact of financial toxicity in patients with gynecologic cancer
New targeted therapy provides survival benefit in KRAS G12C-mutated lung cancer